New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 2, 2014
07:58 EDTZMHZimmer price target raised to $131 from $110 at Canaccord
Canaccord raised its price target on Zimmer Holdings to $131 from $110 to reflect the acquisition of Biomet. The firm sees a massive new knee product cycle and believes Zimmer is positioned solidly in the global musculoskeletal and OrthoRecon industry. Canaccord maintains its Buy rating on the stock.
News For ZMH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 14, 2014
12:33 EDTZMHZimmer, Stryker have postive read-through from J&J, says Wells Fargo
Subscribe for More Information
11:11 EDTZMHJohnson & Johnson Ortho strength positive for Zimmer, says Piper Jaffray
Piper Jaffray said Johnson & Johnson's (JNJ) sequential Q3 strength in orthopedics, which included acceleration in both hips and knees, was surprising and a positive for Zimmer (ZMH). However, Piper expect sentiments on ortho names to remain muted until further into reporting season, noting that Stryker (SYK) is scheduled to report Thursday after the close. The firm has Neutral rating on Johnson & Johnson and Stryker and an Overweight rating on Zimmer.
October 9, 2014
06:18 EDTZMHBiomet reports Q1 sales up 6% to $775M
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use